Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed within the last 3 years with a condition such as schizophrenia, delusional disorder, or a related psychotic disorder (as classified under a specific medical coding system)
- People who have been identified as being at risk of developing psychosis, based on a structured clinical assessment called the SIPS
- People who experience what are called "anomalous self-experiences" — unusual changes in how they perceive themselves or their sense of identity — confirmed through a specific screening questionnaire (SQuEASE-6)
- People who are willing and motivated to explore these unusual self-experiences through talking therapy (psychotherapy)
Who may not be able to join:
- People who are currently experiencing severe, ongoing psychosis
- People who are currently experiencing severe, ongoing drug or substance misuse
- People with an IQ below 70
- People who do not have a good enough level of proficiency in the Norwegian language
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tor Gunnar Værnes, Dr.philos., Oslo University Hospital, Early Intervention in Psychosis Advisory Unit for South-East Norway
Phone: 0047 92 45 56 78
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Experience of the seven-step phenomenological psychotherapy model for self-disorders
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.